dpp1inhib
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| dpp1inhib [2026/01/29 20:48] – [Introduction] gary1 | dpp1inhib [2026/01/29 20:50] (current) – [DPP-1 inhibitors] gary1 | ||
|---|---|---|---|
| Line 22: | Line 22: | ||
| =====DPP-1 inhibitors===== | =====DPP-1 inhibitors===== | ||
| ***brensocatib (Brinsupri)** | ***brensocatib (Brinsupri)** | ||
| - | * an oral small-molecule inhibitor of dipeptidyl peptidase 1 (DPP1) — approved for Rx of non-cystic fibrosis bronchiectasis by FDA in 2025 | + | * an oral small-molecule inhibitor of dipeptidyl peptidase 1 (DPP1) — approved for Rx of non-cystic fibrosis bronchiectasis by FDA in 2025 but not yet approved in Australia as of Jan 2026 |
| * did not improve clinical status at day 29 in patients hospitalised with COVID-19, in fact, these patients were clinically worse(([[https:// | * did not improve clinical status at day 29 in patients hospitalised with COVID-19, in fact, these patients were clinically worse(([[https:// | ||
dpp1inhib.txt · Last modified: 2026/01/29 20:50 by gary1